This compound is a phosphorylated, methylated guanosine derivative used as a pharmaceutical intermediate for RNA modification research. It features a methylated purine base and a phosphate group on the ribose sugar, with a net neutral charge.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 94889-79-9
[(2R,3S,4R,5R)-5-(2-amino-7-methyl-6-oxo-1H-purin-9-ium-9-yl)-4-hydroxy-3-methoxyoxolan-2-yl]methyl phosphono phosphate;N,N-diethylethanamine
pharmaceutical intermediate
N(1)-methylpseudouridine 5'-monophosphate
RNA modification intermediate
1-Benzyl-4-piperidone oxime
pharmaceutical intermediate
3-Benzoyl-2-(4-methoxyphenyl)-4-phenyloxazolidine-5-carboxylic acid, (4S,5R)-
Pharmaceutical intermediate for paclitaxel
1-(5-CHLOROPYRIDIN-2-YL)ETHAN-1-ONE
pharmaceutical intermediate
2,4-DIHYDROXYBENZALDEHYDE
Pharmaceutical intermediate and building block
7-methylguanosine 5'-(trihydrogen diphosphate)
Pharmaceutical intermediate for nucleotide analogs
[(2R,3R,4R,5R)-5-(2-amino-7-methyl-6-oxo-1H-purin-9-ium-9-yl)-3-hydroxy-4-methoxyoxolan-2-yl]methyl hydrogen phosphate
FHSYAAQTDTXBME-IOSLPCCCSA-N
CN1C=[N+](C2=C1C(=O)NC(=N2)N)[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)[O-])O)OC
—